Metraipolis › archive › dc_e8dae5d89ed2

Predicting Outcomes and Optimizing Therapy in Thrombotic Thrombocytopenic Purpura: Insights on Caplacizumab Use from a Romanian Hematology Center — Europe PMC PMID:41303245

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41303245
DOI
10.3390/jcm14228211
License (as archived)
solo-consultazione
Archived
2026-11-08T10:16:24.544Z
SHA-256 of the archived text
2f32a658e28f21b16bc60a57275a8ef45a5716d880d2f184be7f8ed9d5fcd4b0
Stable URL of this page
https://metraipolis.com/documento/dc_e8dae5d89ed2

How to cite

Predicting Outcomes and Optimizing Therapy in Thrombotic Thrombocytopenic Purpura: Insights on Caplacizumab Use from a Romanian Hematology Center — Europe PMC PMID:41303245 — Europe PMC (en), https://europepmc.org/article/MED/41303245 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e8dae5d89ed2 (Metraipolis archive dc_e8dae5d89ed2, sha256 2f32a658e28f21b16bc60a57275a8ef45a5716d880d2f184be7f8ed9d5fcd4b0)
BibTeX
@misc{dce8dae5d89ed2,
  title = {Predicting Outcomes and Optimizing Therapy in Thrombotic Thrombocytopenic Purpura: Insights on Caplacizumab Use from a Romanian Hematology Center — Europe PMC PMID:41303245},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41303245},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e8dae5d89ed2; sha256 2f32a658e28f21b16bc60a57275a8ef45a5716d880d2f184be7f8ed9d5fcd4b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303245. Agents can read the archived copy with the MCP tool read_document.